Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized Phase II Study of Weekly XELIRI Regimen Versus FOLFIRI in the Treatment of Advanced Colorectal Cancer Patients
Conditions
Interventions
wXELIRI regimen
FOLFIRI regimen
Locations
1
China
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
Start Date
May 1, 2012
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2015
Last Updated
November 29, 2012
NCT06696768
NCT04704661
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions